Hematopoietic Stem Cell Transplantation in a Very High Risk Group of Patients with the Support of Granulocyte Transfusion

被引:0
|
作者
İdil Yenicesu
Gülsan Sucak
Günter Dilsiz
Şahika Zeynep Akı
Zeynep Arzu Yeğin
机构
[1] Gazi University,Faculty of Medicine, Pediatric Hematology and Blood Bank
[2] Gazi University,Faculty of Medicine, Adult Hematology and Stem Cell Transplantation Unit
[3] Kara Elmas University,Faculty of Medicine, Family Medicine Department
来源
Indian Journal of Hematology and Blood Transfusion | 2011年 / 27卷
关键词
Stem cell transplantation; Granulocyte transfusion; Fungal infection; Anti-fungal treatment;
D O I
暂无
中图分类号
学科分类号
摘要
High risk patients with active fungal infection who had undergone hematopoietic stem cell transplantation (HSCT) with the support of granulocyte transfusions (GTX) as an adjunct to antifungal agents are reviewed retrospectively. Patients requiring immediate allogeneic HSCT for their primary hematological disorders (two severe aplastic anemia, one T cell acute lymphoblastic leukemia (ALL) in second complete remission, one acute myeloid leukemia (AML)-in first complete remission, one T-ALL in refractory relapse) but were denied by other transplant programs due to active invasive fungal infections had undergone HSCT with the support of GTX at the stem cell transplantation unit of Gazi University. Five patients who had undergone six transplants were included in the study and received a total of 38 (3–13) granulocyte transfusions during these six transplants. The median granulocyte concentration was 3.4 × 1011 per apheresis bag. Full clinical and radiological recovery was achieved in three of the five high risk patients with active invasive fungal infection with the combination of antifungal agents and GTX. Even a very high risk patient with aplastic anemia who had undergone two consecutive transplants due to secondary graft failure was also cured of his primary disease despite the presence of multiple pulmonary fungus balls. Three of the five patients with very high risk features due to the underlying hematological disease and the associated active fungal infection were rescued with allogeneic HSCT performed with the support of GTX combined with antifungal agents. Despite the limitations of this report due to its retrospective nature, it suggests that GTX might be an alternative in patients with active fungal infections who otherwise are denied by the transplant programs. However, prospective randomized studies are required to draw a solid conclusion regarding the role of GTX in HSCT recipients in desperate situations such as active fungal infections.
引用
收藏
页码:146 / 151
页数:5
相关论文
共 50 条
  • [21] Allogeneic hematopoietic stem cell transplantation in the treatment of very high-risk acute leukemia in children.
    Stary, J
    Kobylka, P
    Sedlacek, P
    Komrska, V
    Vavra, V
    Syruckova, Z
    Smisek, P
    Hruba, A
    Korinkova, P
    Matejkova, E
    Cukrova, V
    Dolezalova, L
    Loudova, M
    Sejkorova, J
    Kvech, J
    BONE MARROW TRANSPLANTATION, 1998, 21 : S1 - S1
  • [22] Complex Transfusion Issues in Pediatric Hematopoietic Stem Cell Transplantation
    Webb, Jennifer
    Abraham, Allistair
    TRANSFUSION MEDICINE REVIEWS, 2016, 30 (04) : 202 - 208
  • [23] PREDICTING TRANSFUSION REQUIREMENTS IN PEDIATRIC PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Qawasmi, Ahmed
    Ozgonenel, Bulent
    Savasan, Sureyya
    Ravindranath, Yaddanapudi
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S99 - S99
  • [24] Granulocyte Transfusion Therapy in Pediatric Patients After Hematopoietic Stem Cell Transplantation: A 5-Year Single Tertiary Care Center Experience
    Pham, Huy P.
    Rogoza, Kim
    Stotler, Brie
    Duffy, Deirdre
    Parker-Jones, Sylvia
    Ginzburg, Yelena
    Bhatia, Monica
    Cairo, Mitchell
    Schwartz, Joseph
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, 34 (08) : E332 - E336
  • [25] Cardiovascular Risk in Patients before and after Hematopoietic Stem Cell Transplantation
    Sossa, Claudia
    Ardila-Baez, Manuel
    Wandurraga, Edwin
    Serrano, Sergio
    Luna-Gonzalez, Maria
    Salazar, Luis A.
    Jimenez, Sara I.
    Rosales, Manuel
    Pena, Angela M.
    Chen, Xueyi
    Rey, Juan J.
    Chacon, Maria A.
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 426 - 427
  • [27] Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
    Naithani, Rahul
    Dayal, Nitin
    Rai, Reeta
    SOUTH ASIAN JOURNAL OF CANCER, 2020, 9 (04) : 233 - 235
  • [28] Safety and Feasibility of Granulocyte Transfusion for High-Risk Allogenic Stem Cell Transplant Recipients
    Rafique, Amina
    Winstead, Michael
    Windreich, Randy
    Rowan, Jason
    Yazer, Mark
    Szabolcs, Paul
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S56 - S56
  • [29] Comparison of Prophylactic and Preemptive Donor Lymphocyte Infusion in Patients with Very High Risk Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Yang, Luxin
    Luo, Yi
    Huang, He
    Tan, Yamin
    Shi, Jimin
    Zhao, Yanmin
    Yu, Jian
    Lai, Xiaoyu
    BLOOD, 2021, 138 : 3860 - +
  • [30] Very High Risk Acute Lymphoblastic Leukemia: Comparison Between Chemotherapy and Hematopoietic Stem Cell Transplantation in First Remission
    Osorio Name, N.
    Serrano Bueno, M. J.
    Guitter, M.
    Alfaro, E.
    Sanchez La Rosa, C.
    Rossi, J.
    Figueroa, C.
    Staciuk, R.
    Felice, M. S.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S250 - S251